A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab

NCT04998851 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis
Clinically Isolated Syndrome

Interventions

DRUG: Ocrelizumab

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]
[object Object]
[object Object]